Results 1 to 10 of about 16,702,141 (260)
De acordo com os critérios adotados, estão habilitados a submeter artigos para publicação em uma Seleta de CNMAC aqueles autores que apresentaram os correspondentes trabalhos no evento.
Volume 9(3) - TEMA
doaj +10 more sources
Archaeology & Brazilian Studies: Past and Present Arqueologia e Estudos Brasilieros: pasado e ...
Felipe Botelho Correa
doaj +1 more source
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Volume 9, Nomor 2, Desember ...
Jentera: Jurnal Kajian Sastra Volume 9, Nomor 2, Desember 2020
doaj
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source
Volume 9, Nomor 2, Desember ...
Jentera: Jurnal Kajian Sastra Volume 9, Nomor 2, Desember 2020
doaj
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
Volume 9, Nomor 2, Desember ...
Jentera: Jurnal Kajian Sastra Volume 9, Nomor 2, Desember 2020
doaj
This issue is our fourth Students, Transitions, Achievement, Retention and Success (STARS) Conference special issue (July 8-11 July, Auckland, New Zealand).
Karen Nelson, Tracy Creagh
doaj +1 more source
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source

